Assyro AI

Orange Book product · Brand (NDA)

BYVALSON

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Brand (NDA)NDA 206302DISCN ABBVIE

At a glance

Jun 03, 2016

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 03, 2016

    10 yr 2 mo ago

  2. Today

  3. Patent 7803838 expires

    Listed drug product patent expiration.

    Aug 29, 2026

    in 2 mo

  4. Patent 7838552 expires

    Listed method-of-use patent (U-185) expiration.

    Oct 04, 2027

    in 1 yr 4 mo

Pharmaceutical detail

Active ingredient

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Strength

EQ 5MG BASE;80MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 206302

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7803838Aug 29, 2026in 2 mo
Product
7838552Oct 04, 2027in 1 yr 4 mo
U-185
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.